Found 299 matching trials
Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
PHASE1This study investigated a 4-week adjunctive therapy of either a GLP-1 analo...
Location
Profil Institut für Stoffwechselforschung GmbH
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors
PHASE4Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Location
Kurume University Hospital
Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes
PHASE4The study is a multicenter, prospective, open-label, randomized pilot study...
Location
Grady Memorial Hospital
Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients
PHASE1This study will evaluate the pharmacokinetics of vildagliptin (LAF237) and ...
Location
Novartis Investigator Site
A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine
PHASE2This study compares insulin 287 (a possible new medicine) to insulin glargi...
Location
Novo Nordisk Investigational Site
Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus
PHASE2Diabetes mellitus (DM) is a complex metabolic disorder characterized by hyp...
Location
Faculty of medicine, Tanta University
Sitagliptin in Cystic Fibrosis-Related Diabetes
PHASE2The purpose of this study is to determine whether the dipeptidyl peptidase ...
Location
University of British Columbia Gerontology & Diabetes Reserach Centre (ViTALITY)
DBPR108 Tablets in Type 2 Diabetes Mellitus Patients
PHASE2This study evaluate DRBP108 in the treatment of type 2 diabetes mellitus. T...
Location
First Hospital of Peking Unversity
Empagliflozin in Treatment of Peripheral Diabetic Neuropathy
PHASE1The aim of the study is to investigate the possible protective effect of em...
Location
Faculty of pharmacy
The Effect of DPP4 Inhibitor on Vasclular Healing
PHASE4This study evaluate the effect of dipeptidyl-peptidase 4 inhibitor on vascu...
Location
Keimyung University Hospital